MNKD Mannkind PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: MNKD
- PE Ratio
As of Jul 29, 2025, the Mannkind stock's PE ratio is 38.2. This takes into account the latest EPS of $0.1 and stock price of $3.82. The PE ratio marks a decrease of 49% from its last 4 quarters average of 74.4.
MNKD PE ratio history
The PE ratio of Mannkind has averaged 51.91 over the last nine years. The current P/E ratio of 38.2 is 26% lower than the historical average. Looking back at the last nine years, MNKD's PE ratio peaked in the Mar 2024 quarter at 113.25, when the price was $4.53 and the EPS was $0.04. The lowest point was in the Jun 2017 quarter, when it reached 1.02 with a price of $1.41 and an EPS of $1.38.
Mannkind PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 64.3 | N/A | $6.43 | $0.1 |
| 2023 | N/A | N/A | $3.64 | -$0.04 |
| 2022 | N/A | N/A | $5.27 | -$0.34 |
| 2021 | N/A | N/A | $4.37 | -$0.32 |
| 2020 | N/A | N/A | $3.13 | -$0.26 |
| 2019 | N/A | N/A | $1.29 | -$0.27 |
| 2018 | N/A | N/A | $1.06 | -$0.6 |
| 2017 | N/A | N/A | $2.32 | -$1.13 |
| 2016 | 2.32 | N/A | $3.18 | $1.37 |
| 2015 | N/A | N/A | $7.25 | -$4.54 |
| 2014 | N/A | N/A | $26.08 | -$2.57 |
| 2013 | N/A | N/A | $26 | -$3.2 |
| 2012 | N/A | N/A | $11.55 | -$4.7 |
| 2011 | N/A | N/A | $12.5 | -$6.6 |
| 2010 | N/A | N/A | $40.3 | -$7.5 |
Mannkind PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 50.3 | -21.77% | $5.03 | $0.1 |
| Dec 2024 | 64.3 | -18.22% | $6.43 | $0.1 |
| Sep 2024 | 78.63 | -24.68% | $6.29 | $0.08 |
| Jun 2024 | 104.4 | -7.81% | $5.22 | $0.05 |
| Mar 2024 | 113.25 | N/A | $4.53 | $0.04 |
| Dec 2023 | N/A | N/A | $3.64 | -$0.04 |
| Sep 2023 | N/A | N/A | $4.13 | -$0.12 |
| Jun 2023 | N/A | N/A | $4.07 | -$0.19 |
| Mar 2023 | N/A | N/A | $4.1 | -$0.28 |
| Dec 2022 | N/A | N/A | $5.27 | -$0.34 |
| Sep 2022 | N/A | N/A | $3.09 | -$0.38 |
| Jun 2022 | N/A | N/A | $3.81 | -$0.34 |
| Mar 2022 | N/A | N/A | $3.68 | -$0.37 |
| Dec 2021 | N/A | N/A | $4.37 | -$0.32 |
| Sep 2021 | N/A | N/A | $4.35 | -$0.33 |
MNKD Price vs fair value
MNKD average PE ratio chart
MNKD's current PE ratio is lower than its 3, 5 and 10-year averages.
MNKD PE vs peers
MNKD's PE ratio stands lower than its peer stock LLY, but it is higher than MRK's and PFE's. Mannkind's current PE ratio of 38.2 is higher than the average of its peers, which is 26.66.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.99 | $207.49B |
| HALO Halozyme Therapeutics Inc | 15.34 | $7.28B |
| PFE Pfizer Inc | 17.48 | $138.15B |
| MNKD Mannkind Corp | 38.2 | $1.16B |
| LLY ELI LILLY & Co | 61.83 | $723.07B |
| NKTR Nektar Therapeutics | N/A | $284.24M |
Frequently asked questions
What is Mannkind's PE ratio?
The price to earnings ratio for MNKD stock is 38.2 as of Jul 29, 2025.
What is the 3-year average PE ratio for Mannkind (MNKD)?
The average PE ratio for MNKD stock over the past 3 years is 82.18.
What is the 5-year average PE ratio for Mannkind (MNKD)?
The average PE ratio for MNKD stock over the past 5 years is 82.18.
What is the highest PE ratio for MNKD?
The highest quarterly PE ratio in the last nine years has been 113.25 and it was in the Mar 2024 quarter.
How does the current PE ratio for MNKD compare to its historical average?
MNKD's price to earnings ratio is currently 26% below its 9-year historical average.
How is MNKD's PE ratio calculated (Mannkind PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 29, 2025), Mannkind's share price is $3.82. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.1. Therefore, Mannkind's PE ratio for today is 38.2. PE RATIO(38.2) = STOCK PRICE($3.82) / TTM EPS($0.1)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.